Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

23.89 -0.29 (-1.18%)
Streaming Delayed Price Updated: 2:30 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
Although monetary policy seemed to be moving in a dovish direction, a pivot may warrant a look at stocks for Fed hikes. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income. 
Via InvestorPlace
Johnson & Johnson is as Cheap as it’s Going to Get
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely. 
Via MarketBeat
Beyond The Numbers: 5 Analysts Discuss Kenvue Stock
Via Benzinga
How Is The Market Feeling About Kenvue?
Via Benzinga
The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash
You never know when a downturn will hit so it pays to prepare for the worst by buying these stocks before a market crash. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Wall Street's Top 10 Stock Calls This Week - Saturday, April 13
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of April 8-12, 2024. 
Via Talk Markets
Stocks Surge, Goldgasms To Record High After "Adjusted" PPI Sparks Buying Frenzy
What started off as another ugly day with stocks tumbling and yields surging following yesterday's VaR-shock-inducing CPI print, quickly reversed after the market - in its infinite stupidity - took... 
Via Talk Markets
Dow Off Triple Digits As Nasdaq Inches Higher
Stocks are all over the place this afternoon. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024. 
Via InvestorPlace
Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating. 
Via InvestorPlace
Thermo Fisher Layoffs 2024: What to Know About the Latest TMO Job Cuts
Thermo Fisher layoffs are in the news Tuesday after the company announced plans to cut 74 jobs at its plasmid manufacturing location. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
BB Stock Alert: 5 Things to Know About the New AMD-BlackBerry Partnership
BlackBerry stock is rising higher on Tuesday after it announced a robotics development partnership with Advanced Micro Devices. 
Via InvestorPlace
Toncoin (TON) Crypto Overtakes the No. 9 Spot in Major Move Higher
Toncoin is heading higher on Tuesday as crypto traders celebrate the token rising to the ninth spot by market capitalization. 
Via InvestorPlace
SMCI Stock: Super Micro Computer Announces a New Smart City Deal
Super Micro Computer stock is down on Tuesday as SMCI investors appear unimpressed by its collaboration non smart city development. 
Via InvestorPlace
Kenvue Layoffs 2024: What to Know About the Latest Neutrogena Job Cuts
Kenvue is cutting 135 jobs at Neutrogena. Here's what investors need to know about the Kenvue layoffs and why KVUE stock is still up. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
How's AT&T Handling Things?
We've also got a look at 3M's spinoff, gold prices, and the beef industry. 
Via The Motley Fool
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Income-seeking investors can look forward to steady payout raises from these pharma stocks. 
Via The Motley Fool
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend 
Via MarketBeat
Kenvue to Announce First Quarter 2024 Results on May 7, 2024
From Kenvue Inc.
Via Business Wire
Why 3M Stock Was Moving Higher Today
Investors applauded the spin-off of its healthcare business. 
Via The Motley Fool
Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?
Although 3M shareholders have reason to dump the Solventum spinoff, SOLV stock could be intriguing at the right price. 
Via InvestorPlace
3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff
Investors are split over the upcoming launch of 3M's healthcare spinoff, Solventum. What does the spinoff mean for 3M stock? 
Via InvestorPlace
Dear 3M Stock Fans, Mark Your Calendars for April 1
Investors are split on MMM stock ahead of 3M's long-awaited healthcare spinoff, Solventum, launching April 1. 
Via InvestorPlace
Should You Buy 3M Before April 1?
A looming stock spinoff should give investors a reason to pause. 
Via The Motley Fool
7 Defensive Stocks to Build a Moat Around Your Portfolio
Although the market seems to continuously be on the rise, some concerning data suggests investors should consider defensive stocks. 
Via InvestorPlace
Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own
Investing in your golden years is about choosing stocks for retirees that are low-risk, offer passive income and steadily grow. 
Via InvestorPlace
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Johnson & Johnson's days of being a top healthcare stock could be long gone. 
Via The Motley Fool
The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough
Dive into tax season stocks, featuring dividend-rich JNJ and EQIX, plus growth-focused TSLA, for a smarter tax season strategy. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.